Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase.
about
General control nonderepressible 2 deletion predisposes to asparaginase-associated pancreatitis in mice.Targeting asparagine and autophagy for pulmonary adenocarcinoma therapy.Do immunoglobulin G and immunoglobulin E anti-l-asparaginase antibodies have distinct implications in children with acute lymphoblastic leukemia? A cross-sectional studyDeprivation of asparagine triggers cytoprotective autophagy in laryngeal squamous cell carcinoma.Autophagy suppression potentiates the anti-glioblastoma effect of asparaginase in vitro and in vivo.Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation.
P2860
Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Asparaginase Erwinia chrysanth ...... E. coli-derived asparaginase.
@en
type
label
Asparaginase Erwinia chrysanth ...... E. coli-derived asparaginase.
@en
prefLabel
Asparaginase Erwinia chrysanth ...... E. coli-derived asparaginase.
@en
P2093
P2860
P921
P1476
Asparaginase Erwinia chrysanth ...... E. coli-derived asparaginase.
@en
P2093
Lisa Figueiredo
Peter D Cole
Richard A Drachtman
P2860
P304
P356
10.1586/17474086.2016.1142370
P577
2016-01-14T00:00:00Z